Aspira Women's Health Faces Delisting Notice

Ticker: AWHL · Form: 8-K · Filed: 2024-12-31T00:00:00.000Z

Sentiment: bearish

Topics: delisting, listing-rule-violation, company-update

TL;DR

Aspira Women's Health (AWH) got a delisting warning, might be in trouble.

AI Summary

Aspira Women's Health Inc. filed an 8-K on December 31, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems.

Why It Matters

This filing indicates potential issues with Aspira Women's Health's continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.

Key Players & Entities

Aspira Women's Health Inc. (company) — Registrant
December 31, 2024 (date) — Date of earliest event reported
Vermillion, Inc. (company) — Former company name
Ciphergen Biosystems Inc (company) — Former company name
Abiotic Systems (company) — Former company name

FAQ

What specific listing rule did Aspira Women's Health Inc. fail to satisfy?

The filing does not specify the exact listing rule that was not satisfied, only that a notice of delisting or failure to satisfy a continued listing rule was issued.

When was the notice of delisting or failure to satisfy a continued listing rule issued?

The earliest event reported in this 8-K filing is dated December 31, 2024, which is when the notice was likely issued or became effective.

What are the previous names of Aspira Women's Health Inc.?

Aspira Women's Health Inc. was formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems.

What is the business address of Aspira Women's Health Inc.?

The business address is 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.

What is the SIC code for Aspira Women's Health Inc.?

The Standard Industrial Classification (SIC) code for Aspira Women's Health Inc. is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.

From the Filing

0001493152-24-052755.txt : 20241231 0001493152-24-052755.hdr.sgml : 20241231 20241231172141 ACCESSION NUMBER: 0001493152-24-052755 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241231 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20241231 DATE AS OF CHANGE: 20241231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 241593810 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 form8-k.htm false 0000926617 0000926617 2024-12-31 2024-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2024       Aspira Women’s Health Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-34810   33-0595156 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   12117 Bee Caves Road Building III Suite 100     Austin, Texas   78738 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: 512 519-0400     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001 per share   AWH   The Nasdaq Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.   As Aspira Women’s Health Inc. (t